2m 2m 2m 2m 2m 2m 2m
QIAGEN (QGEN)
NYSE
$37.15+$0.87 (+2.40%)
Price as of Jun 23, 2026 1:38 PM EDT- $7.5BMarket Cap
- -17.95%1-Year Change
- Diagnostics & ResearchIndustry
QIAGEN (QGEN)
$37.15+$0.87 (+2.40%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.1B +5.65% | 2.0B +0.66% | 2.0B -8.23% | 2.1B -4.89% | |
Cost of Revenue | 790.5M -21.80% | 1.0B +38.17% | 731.6M -3.35% | 757.0M -5.48% | |
Gross Profit | 1.3B +34.34% | 967.4M -21.59% | 1.2B -10.90% | 1.4B -4.57% | |
Sales and Marketing Expense | 458.0M +1.57% | 450.9M -1.95% | 459.9M -3.02% | 474.2M +3.91% | |
Research and Development Expense | -187.5M -3.09% | -193.5M -2.53% | -198.5M +4.56% | -189.9M -0.06% | |
Depreciation and Amortization Expense | 193.7M -4.68% | 203.3M -1.01% | 205.3M -1.47% | 208.4M -3.04% | |
Total Operating Expenses | 833.6M -4.14% | 869.6M +5.57% | 823.8M -3.44% | 853.1M +3.94% | |
Operating Profit | 465.9M +376.76% | 97.7M -76.16% | 409.9M -22.87% | 531.5M -15.65% | |
Interest Income | 64.3M -5.43% | 68.0M -13.90% | 79.0M +141.15% | 32.8M +242.83% | |
Interest Expense | -20.9M -20.73% | -26.4M -50.63% | -53.4M -8.48% | -58.4M +7.12% | |
Interest Income and Expense and Net | 43.4M +4.25% | 41.6M +62.80% | 25.6M +199.93% | -25.6M -43.01% | |
Total Nonoperating Income and Expense | 24.4M +4.17% | 23.4M +17.94% | 19.9M +205.37% | -18.9M +343.64% | |
Income before Taxes | 490.3M +304.69% | 121.1M -71.81% | 429.8M -16.15% | 512.6M -18.09% | |
Income Taxes | 65.4M +74.10% | 37.6M -57.57% | 88.5M -0.99% | 89.4M -21.06% | |
Extraordinary Items | 22.4M -88.97% | 203.4M +4,791.97% | 4.2M -67.94% | 13.0M N/A | |
Net Income | 424.9M +408.28% | 83.6M -75.51% | 341.3M -19.35% | 423.2M -17.44% | |
Net Income from Continuing Operations Applicable to Common | 490.3M +304.69% | 121.1M -71.81% | 429.8M -16.15% | 512.6M -18.09% | |
Basic EPS and Net Income | 1.96 +415.79% | 0.38 -74.67% | 1.50 -19.35% | 1.86 -17.33% | |
Diluted EPS and Net Income | 1.94 +424.32% | 0.37 -75.00% | 1.48 -19.57% | 1.84 -16.74% | |
Basic Weighted Average Shares | 217.2M -2.43% | 222.6M -2.42% | 228.1M +0.25% | 227.6M -0.18% | |
Diluted Weighted Average Shares | 218.9M -2.60% | 224.7M -2.56% | 230.6M +0.21% | 230.1M -0.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 839.0M +26.44% | 663.6M -0.68% | 668.1M -8.57% | 730.7M -17.02% | |
Short-Term Investments | 259.9M -46.90% | 489.4M +25.59% | 389.7M -43.32% | 687.6M +272.11% | |
Cash and Cash Equivalents and Short-Term Investments | 1.1B -4.69% | 1.2B +9.00% | 1.1B -25.42% | 1.4B +33.13% | |
Total Current Assets | 2.0B +1.80% | 2.0B -8.74% | 2.1B -10.29% | 2.4B +13.48% | |
Accumulated Depreciation | 465.0M -9.95% | 516.3M -0.09% | 516.8M +2.74% | 503.0M -20.47% | |
Property and Plant and Equipment and Net | 923.9M +22.60% | 753.6M -1.49% | 765.0M +15.53% | 662.2M +3.76% | |
Total Long-Term Assets | 4.3B +14.92% | 3.7B -6.00% | 4.0B +1.90% | 3.9B -3.56% | |
Total Assets | 6.3B +10.40% | 5.7B -6.96% | 6.1B -2.74% | 6.3B +2.29% | |
Income Taxes Payable | 66.3M +39.19% | 47.6M +88.51% | 25.3M -19.71% | 31.5M -16.26% | |
Total Short-Term Debt | 0 -100.00% | 53.5M -90.90% | 588.0M +50.93% | 389.6M -54.04% | |
Total Current Liabilities | 512.1M -5.79% | 543.6M -49.63% | 1.1B +10.75% | 974.5M -35.78% | |
Total Long-Term Debt | 1.7B +23.64% | 1.3B +45.15% | 921.8M -37.37% | 1.5B +34.53% | |
Total Long-Term Liabilities | 2.0B +26.12% | 1.6B +28.54% | 1.2B -33.49% | 1.8B +20.46% | |
Total Liabilities | 512.1M -5.79% | 543.6M -49.63% | 1.1B +10.75% | 974.5M -35.78% | |
Retained Earnings | 2.7B +12.27% | 2.4B -0.35% | 2.5B +13.73% | 2.2B +20.56% | |
Total Stockholders Equity | 3.8B +5.91% | 3.6B -6.31% | 3.8B +9.84% | 3.5B +11.95% | |
Total Shares Outstanding | 217.7M -2.78% | 223.9M -3.00% | 230.8M 0.00% | 230.8M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 654.3M -2.85% | 673.6M +46.60% | 459.5M -35.76% | 715.3M +11.93% | |
Capital Expenditures | 201.0M +20.26% | 167.2M +11.67% | 149.7M +15.85% | 129.2M -31.95% | |
Cash from Investing Activities | -305.3M +22.49% | -249.2M +184.33% | -87.7M -87.94% | -726.8M +259.03% | |
Dividends Paid | 54.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -179.0M -57.68% | -422.9M -2.52% | -433.8M +244.85% | -125.8M -16.34% | |
Financials Ratio | |||||
Gross Margin | 62.18% +27.15% | 48.90% -22.10% | 62.77% -2.91% | 64.65% +0.34% | |
Operating Margin | 22.29% +351.26% | 4.94% -76.32% | 20.86% -15.95% | 24.82% -11.31% | |
Return on Assets | 7.10% +401.24% | 1.42% -74.27% | 5.50% -19.15% | 6.81% -19.93% | |
Return on Equity | 11.57% +410.34% | 2.27% -75.84% | 9.38% -27.24% | 12.90% -25.85% | |
Revenue Growth | 5.65% +760.75% | 0.66% +107.98% | -8.23% +68.21% | -4.89% -123.99% | |
Current Ratio | 3.90 +8.06% | 3.61 +81.18% | 1.99 -19.00% | 2.46 +76.70% | |
Cash Ratio | 1.64 +34.21% | 1.22 +97.19% | 0.62 -17.44% | 0.75 +29.21% | |
Debt-to-Equity Ratio | 0.44 +12.25% | 0.39 -1.61% | 0.40 -26.16% | 0.54 -14.37% | |
Debt-to-Assets Ratio | 0.26 +7.69% | 0.24 -0.93% | 0.25 -16.59% | 0.30 -6.30% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow